title: Gefitinib versus docetaxel for previously treated NSCLC--letter.
authors.forename: Davide
authors.initials: D
authors.lastname: Tassinari
authors.forename: Luigi
authors.initials: L
authors.lastname: Lazzari-Agli
authors.forename: Paola
authors.initials: P
authors.lastname: Tombesi
authors.forename: Sergio
authors.initials: S
authors.lastname: Sartori
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D043823:Taxoids